One of the Kirby Institute's long-time champions has been appointed as its new Director and "could not be prouder" to carry on the Institute's life-saving research.
A global-first, UNSW-led trial of an HIV prevention medication has resulted in an almost one-third decline in infections in the large-scale target group.
New reports released today show that increases in government funding for prevention strategies are achieving significant reductions in the risk of HIV transmission.
Researchers from the Kirby Institute say its time to remove restrictions that prevent recent drug users from accessing successful hepatitis C treatment.
Point-of-care tests to detect and treat key infectious diseases will be expanded in 300 health centres in four countries thanks to a new program led by UNSW.
Newly released data from the Kirby Institute show a decline in the uptake of life-saving treatments among people living with hepatitis C.
New research from NDARC and the Kirby Institute at UNSW Sydney shows almost 40% of people who have injected drugs in the past year are living with hepatitis C.
A study led by the Kirby Institute at UNSW supports evidence that treatment-as-prevention allows people living with HIV to have effectively zero chance of sexually transmitting the virus to others.
A symposium of distinguished guests supported a research agenda to perpetuate the legacy of the late Professor David Cooper.
Hundreds of people gathered at Sydney's Town Hall today to remember UNSW Scientia Professor David Cooper AC, immunologist and pioneer in the fight against HIV/AIDS.